Cholinergic dysfunction, neuronal damage and axonal loss in TgCRND8 mice

Neurobiology of Disease

Volumn 23, Issue 2, 2006, Pages 260-272

  Bellucci, Arianna ^a   Luccarini, Ilaria ^a   Scali, Carla ^a   Prosperi, Costanza ^a   Giovannini, Maria Grazia ^a   Pepeu, Giancarlo ^a   Casamenti, Fiorella ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Alzheimer's disease; APP transgenic mice; Axonal damage; ChAT positive neurons; Cognitive functions; Extracellular acetylcholine levels; Glia reaction; Muscarinic m2 receptors; White matter demyelination

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MUSCARINIC M2 RECEPTOR; SCOPOLAMINE;

ACETYLCHOLINE BRAIN LEVEL; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN CORTEX; CELL ULTRASTRUCTURE; CHOLINERGIC NERVE CELL; COGNITIVE DEFECT; CONTROLLED STUDY; DEMYELINATING DISEASE; GLIA CELL; IMMUNOREACTIVITY; LEARNING DISORDER; MAGNOCELLULAR NUCLEUS; MEMORY DISORDER; MICRODIALYSIS; MOUSE; MOUSE STRAIN; NERVE CELL LESION; NERVE DEGENERATION; NERVE FIBER DEGENERATION; NEUROPATHOLOGY; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; SPECIES COMPARISON; WHITE MATTER;

ACETYLCHOLINE; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AXONS; CHOLINE O-ACETYLTRANSFERASE; COLORING AGENTS; HUMANS; INDOLES; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; NEURONS; RECEPTOR, MUSCARINIC M2;

EID: 33746041397     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2006.03.012     Document Type: Article

References (61)

1. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 21 (2000) 383-421
2. Apelt J., Kumar A., and Schliebs R. Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein. Brain Res. 953 (2002) 17-30
3. Bartus R.T. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp. Neurol. 163 (2000) 495-529
4. Benedetti F., Vighetti S., Ricco C., Lagna E., Bergamasco B., Pinessi L., and Rainero I. Pain threshold and tolerance in Alzheimer's disease. Pain 80 (1999) 377-382
5. Benedetti F., Arduino C., Vighetti S., Asteggiano G., Tarenzi L., and Rainero I. Pain reactivity in Alzheimer patients with different degrees of cognitive impairment and brain electrical activity deterioration. Pain 111 (2004) 22-29
6. Biegon A., Eberling J.L., Richardson B.C., Roos M.S., Wong S.T., Reed B.R., and Jagust W.J. Human corpus callosum in aging and Alzheimer's disease: a magnetic resonance imaging study. Neurobiol. Aging 15 (1994) 393-397
7. Bronfman F.C., Moechars D., and Van Leuven F. Acetylcholinesterase-positive fiber deafferentation and cell shrinkage in the septohippocampal pathway of aged amyloid precursor protein london mutant transgenic mice. Neurobiol. Dis. 7 (2000) 152-168
8. Brun A., and Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann. Neurol. 19 (1986) 253-262
9. Calabrese V., Boyd-Kimball D., Scapagnini G., and Butterfield D.A. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes. In Vivo 18 (2004) 245-267
10. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P.E., Carlson G.A., George-Hyslop P.S., and Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276 (2001) 21562-21570
11. Douglas C.L., Baghdoyan H.A., and Lydic R. M2 muscarinic autoreceptors modulate acetylcholine release in prefrontal cortex of C57BL/6J mouse. J. Pharmacol. Exp. Ther. 299 (2001) 960-966
12. Dudal S., Krzywkowski P., Paquette J., Morissette C., Lacombe D., Tremblay P., and Gervais F. Inflammation occurs early during the Aβ deposition process in TgCRND8 mice. Neurobiol. Aging 25 (2004) 861-871
13. Fernandez-Vizarra P., Fernandez A.P., Castro-Blanco S., Encinas J.M., Serrano J., Bentura M.L., Munoz P., Martinez-Murillo R., and Rodrigo J. Expression of nitric oxide system in clinically evaluated cases of Alzheimer's disease. Neurobiol. Dis. 15 (2004) 287-305
14. Feuerstein T.J., Lehmann J., Sauermann W., van Velthoven V., and Jackisch R. The autoinhibitory feedback control of acetylcholine release in human neocortex tissue. Brain Res. 572 (1992) 64-71
15. German D.C., Yazdani U., Speciale S.G., Pasbakhsh P., Games D., and Liang C.L. Cholinergic neuropathology in a mouse model of Alzheimer's disease. J. Comp. Neurol. 462 (2003) 371-381
16. Giovannelli L., Scali C., Faussone-Pellegrini M.S., Pepeu G., and Casamenti F. Long-term changes in the aggregation state and toxic effects of β-amyloid injected into the rat brain. Neuroscience 87 (1998) 349-357
17. Giovannini M.G., Scali C., Prosperi C., Bellucci A., Vannucchi M.G., Rosi S., Pepeu G., and Casamenti F. Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway. Neurobiol. Dis. 11 (2002) 257-274
18. Gonzalez-Scarano F., and Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. Annu. Rev. Neurosci. 22 (1999) 219-240
19. Griffin W.ST., Sheng J.G., Royston M.C., Gentleman S.M., McKenzie J.E., Graham D.I., Roberts G.W., and Mrak R.E. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'Cytokine Cycle' in disease progression. Brain Pathol. 8 (1998) 65-72
20. Haga S., Akai K., and Ishii T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol. (Berl) 77 (1989) 569-575
21. Halliday G., Robinson S.R., Shepherd C., and Kril J. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms. Clin. Exp. Pharmacol. Physiol. 27 (2000) 1-8
22. Heneka M.T., and Feinstein D.L. Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 114 (2001) 8-18
23. Hernandez D., Sugaya K., Qu T., McGowan E., Duff K., and McKinney M. Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes. NeuroReport 12 (2001) 1377-1384
24. Hiramatsu M., and Inoue K. Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory. Eur. J. Pharmacol. 395 (2000) 149-156
25. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-106
26. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., Chishti M.A., Horne P., Heslin D., French J., Mount H.T., Nixon R.A., Mercken M., Bergeron C., Fraser P.E., George-Hyslop P., and Westaway D. Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408 (2000) 979-982
27. Janus C., Welzl H., Hanna A., Lovasic L., Lane N., George-Hyslop P., and Westaway D. Impaired conditioned taste aversion learning in APP transgenic mice. Neurobiol. Aging 25 (2004) 1213-1219
28. Kobayashi K., Hayashi M., Nakano H., Fukutani Y., Sasaki K., Shimazaki M., and Koshino Y. Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 28 (2002) 238-251
29. Le T.V., Crook R., Hardy J., and Dickson D.W. Cotton wool plaques in non-familial late-onset Alzheimer disease. J. Neuropathol. Exp. Neurol. 60 (2001) 1051-1061
30. Lovasic L., Bauschke H., and Janus C. Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer's disease. Genes Brain Behav. 4 (2005) 197-208
31. Luth H.J., Apelt J., Ihunwo A.O., Arendt T., and Schliebs R. Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice. Brain Res. 977 (2003) 16-22
32. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., and Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16 (1996) 5796-5811
33. McGeer P.L., and McGeer E.G. Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions. Alzheimer Dis. Assoc. Disord. 12 Suppl. 2 (1998) S1-S6
34. McGeer P.L., and McGeer E.G. Local neuroinflammation and the progression of Alzheimer's disease. J. Neurovirol. 8 (2002) 529-538
35. Molenar P.C., and Polak R.L. Stimulation by atropine of acetylcholine release and synthesis in cortical slices of rat brain. Br. J. Pharmacol. 40 (1970) 406-417
36. Mufson E.J., Jaffar S., and Levey A.I. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya. J. Comp. Neurol. 392 (1998) 313-329
37. Nagele R.G., D'Andrea M.R., Lee H., Venkataraman V., and Wang H.Y. Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res. 971 (2003) 197-209
38. O'Brien J.T., and Ames D. White matter lesions in depression and Alzheimer's disease. Br. J. Psychiatry 169 (1996) 671
39. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates (2001), Academic Press
40. Perry R.J., and Hodges J.R. Attention and executive deficits in Alzheimer's disease. A critical review. Brain 122 Pt 3 (1999) 383-404
41. Perry G., Raina A.K., Nunomura A., Wataya T., Sayre L.M., and Smith M.A. How important is oxidative damage? Lessons from Alzheimer's disease. Free Radical Biol. Med. 28 (2000) 831-834
42. Petkov V.V., and Vuglenova Y. Pharmacological restoration of scopolamine-impaired memory. Acta Physiol. Pharmacol. Bulg. 11 (1985) 37-43
43. Prosperi C., Scali C., Barba M., Bellucci A., Giovannini M.G., Pepeu G., and Casamenti F. Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Aβ(1-42)-induced brain inflammation and neuronal damage in the rat. Int. J. Immunopathol. Pharmacol. 17 (2004) 317-330
44. Rodrigo J., Fernandez-Vizarra P., Castro-Blanco S., Bentura M.L., Nieto M., Gomez-Isla T., Martinez-Murillo R., MartInez A., Serrano J., and Fernandez A.P. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice. Neuroscience 128 (2004) 73-89
45. Rouse S.T., Edmunds S.M., Yi H., Gilmor M.L., and Levey A.I. Localization of M(2) muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus. Neurosci. Lett. 284 (2000) 182-186
46. Scali C., Vannucchi M.G., Pepeu G., and Casamenti F. Peripherally injected scopolamine differentially modulates acetylcholine release in vivo in the young and aged rats. Neurosci. Lett. 197 (1995) 171-174
47. Scali C., Prosperi C., Vannucchi M.G., Pepeu G., and Casamenti F. Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease. Eur. J. Neurosci. 12 (2000) 1900-1912
48. Scali C., Giovannini M.G., Prosperi C., Bellucci A., Pepeu G., and Casamenti F. The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo. Neuroscience 117 (2003) 909-919
49. Scheltens P., Weinstein H.C., and Leys D. Neuro-imaging in the diagnosis of Alzheimer's disease. I. Computer tomography and magnetic resonance imaging. Clin. Neurol. Neurosurg. 94 (1992) 277-289
50. Schmitz C., Rutten B.P., Pielen A., Schafer S., Wirths O., Tremp G., Czech C., Blanchard V., Multhaup G., Rezaie P., Korr H., Steinbusch H.W., Pradier L., and Bayer T.A. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 164 (2004) 1495-1502
51. Selkoe D.J. The genetics and molecular pathology of Alzheimer's disease: roles of amyloid and the presenilins. Neurol. Clin. 18 (2000) 903-922
52. Shytle R.D., Mori T., Townsend K., Vendrame M., Sun N., Zeng J., Ehrhart J., Silver A.A., Sanberg P.R., and Tan J. Cholinergic modulation of microglial activation by α7 nicotinic receptors. J. Neurochem. 89 (2004) 337-343
53. Stout J.C., Jernigan T.L., Archibald S.L., and Salmon D.P. Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type. Arch. Neurol. 53 (1996) 742-749
54. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C., Rothacher S., Ledermann B., Burki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., and Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13287-13292
55. Teipel S.J., Bayer W., Alexander G.E., Zebuhr Y., Teichberg D., Kulic L., Schapiro M.B., Moller H.J., Rapoport S.I., and Hampel H. Progression of corpus callosum atrophy in Alzheimer disease. Arch. Neurol. 59 (2002) 243-248
56. von Bernhardi R., and Eugenin J. Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors. Brain Res. 1025 (2004) 186-193
57. Wong T.P., Debeir T., Duff K., and Cuello A.C. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes. J. Neurosci. 19 (1999) 2706-2716
58. Xu J., Chen S., Ahmed S.H., Chen H., Ku G., Goldberg M.P., and Hsu C.Y. Amyloid-beta peptides are cytotoxic to oligodendrocytes. J. Neurosci. 21 (2001) RC118
59. Yamada T., Tsuboi Y., and Takahashi M. Interrelationship between beta-amyloid deposition and complement-activated oligodendroglia. Dement. Geriatr. Cogn. Disord. 8 (1997) 267-272
60. Yankner B.A., Dawes L.R., Fisher S., Villa-Komaroff L., Oster-Granite M.L., and Neve R.L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245 (1989) 417-420
61. Zhao B. Nitric oxide in neurodegenerative diseases. Front. Biosci. 10 (2005) 454-461